RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses.
Schmitt M, Schmitt A, Rojewski MT, Chen J, Giannopoulos K, Fei F, Yu Y, Götz M, Heyduk M, Ritter G, Speiser DE, Gnjatic S, Guillaume P, Ringhoffer M, Schlenk RF, Liebisch P, Bunjes D, Shiku H, Dohner H, Greiner J.
Schmitt M, et al. Among authors: schmitt a.
Blood. 2008 Feb 1;111(3):1357-65. doi: 10.1182/blood-2007-07-099366. Epub 2007 Oct 31.
Blood. 2008.
PMID: 17978170
Free article.
Clinical Trial.